Literature DB >> 12530047

Correlation of 99mTc-MIBI brain spect (functional index ratios) and survival after treatment failure in malignant glioma patients.

P Beauchesne1, C Soler.   

Abstract

AIM: This preliminary study was conducted to determine the association between 99mTc-SESTAMIBI (MIBI) brain SPECT and survival in malignant glioma patients after treatment failure.
MATERIALS AND METHODS: Twenty-five malignant glioma patients with clinical deterioration were studied. Tomoscintigraphy was performed 15 minutes after intravenous injection of 1110 Mbq MIBI. The images were obtained from a dual head gamma camera using fan beam collimators. Transverse, coronal and sagittal views were reconstructed. Maximum uptake of MIBI in the lesion was expressed as a ratio to that in the controlateral hemisphere.
RESULTS: A MIBI uptake was found in all 25 patients. This uptake was correlated to tumour recurrence proved by histological fragments and/or the rapid fatal evolution of these patients. From scintigraphic parameters, two groups of patients were noted. Group 1 (20 patients) had a significantly better survival time (8.25 months) than did Group 2 (5 patients) (2.9 months). Tumour volume predicted survival (group 1 vs group 2, p < 0.0006). A significant correlation between the tumour/background ratio and survival time for each group was observed.
CONCLUSION: A correlation between functional index ratios and the time of survival of patients was noted. The functional index ratios of brain SPECT are in accordance with the potential aggressiveness of the recurrent malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530047

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  In Reference to Alexiou et al. (Neuro-Oncology 2008;10:104-105). Evaluation of glioma proliferation by 99mTc-Tetrofosmin.

Authors:  Patrick Beauchesne
Journal:  Neuro Oncol       Date:  2008-06-24       Impact factor: 12.300

2.  Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients.

Authors:  Vytenis Deltuva; Adomas Bunevicius; Nemira Jurkiene; Ilona Kulakiene; Arimantas Tamasauskas
Journal:  Oncol Lett       Date:  2012-07-19       Impact factor: 2.967

3.  Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.

Authors:  Florence Prigent-Le Jeune; François Dubois; Sarah Perez; Serge Blond; Marc Steinling
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-19       Impact factor: 9.236

Review 4.  Progress on the diagnosis and evaluation of brain tumors.

Authors:  Huile Gao; Xinguo Jiang
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.